431 related articles for article (PubMed ID: 28088246)
1. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
[TBL] [Abstract][Full Text] [Related]
2. Cost-Minimization and Budget Impact Analysis of a Hexavalent Vaccine (Hexaxim®) in the Colombian Expanded Program on Immunization.
Romero M; Góngora DS; Caicedo ML; Benchabane D; Lopez JG
Value Health Reg Issues; 2021 Dec; 26():150-159. PubMed ID: 34474265
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of the DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study.
Monge S; Hahné SJ; de Melker HE; Sanders EA; van der Ende A; Knol MJ
Lancet Infect Dis; 2018 Jul; 18(7):749-757. PubMed ID: 29752131
[TBL] [Abstract][Full Text] [Related]
4. Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine.
Arístegui J; Usonis V; Coovadia H; Riedemann S; Win KM; Gatchalian S; Bock HL
Int J Infect Dis; 2003 Jun; 7(2):143-51. PubMed ID: 12839717
[TBL] [Abstract][Full Text] [Related]
5. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.
Levine OS; Ortiz E; Contreras R; Lagos R; Vial P; Misraji A; Ferreccio C; Espinoza C; Adlerstein L; Herrera P
Am J Epidemiol; 1993 Jun; 137(11):1221-8. PubMed ID: 8322763
[TBL] [Abstract][Full Text] [Related]
6. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
7. Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.
Zhou F; Bisgard KM; Yusuf HR; Deuson RR; Bath SK; Murphy TV
Pediatrics; 2002 Oct; 110(4):653-61. PubMed ID: 12359777
[TBL] [Abstract][Full Text] [Related]
8. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
[TBL] [Abstract][Full Text] [Related]
9. A new combined DTP-HBV-Hib vaccine--strategy for incorporation of Hib vaccination into childhood immunisation programmes.
Ramkissoon A; Coovadia HM; Jugnundan P; Willems P; Clemens BR
S Afr Med J; 2001 Oct; 91(10):864-9. PubMed ID: 11732460
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
11. Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine.
Olivera I; Grau C; Dibarboure H; Torres JP; Mieres G; Lazarov L; Alvarez FP; Yescas JGL
BMC Health Serv Res; 2020 Apr; 20(1):295. PubMed ID: 32272920
[TBL] [Abstract][Full Text] [Related]
12. Public health impact of Infanrix hexa (DTPa-HBV-IPV/Hib) reimbursement: A study programme in France. Part 1: Evolution of hepatitis B vaccine coverage rates in infants aged less than 27 months, in the general population - the PopCorn study.
Gaudelus J; Vié le Sage F; Dufour V; Lert F; Texier N; Pouriel M; Tehard B; Bréart G
Rev Epidemiol Sante Publique; 2016 Feb; 64(1):23-32. PubMed ID: 26748972
[TBL] [Abstract][Full Text] [Related]
13. Pentavalent DTP vaccine: need to be incorporated in the vaccination program of India.
Verma R; Khanna P; Chawla S
Hum Vaccin Immunother; 2013 Jul; 9(7):1497-9. PubMed ID: 23571225
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.
Gupta M; Prinja S; Kumar R; Kaur M
Health Policy Plan; 2013 Jan; 28(1):51-61. PubMed ID: 22407018
[TBL] [Abstract][Full Text] [Related]
15. An assessment of the value of Haemophilus influenzae type b conjugate vaccine in Asia.
Miller MA
Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S152-9. PubMed ID: 9781750
[TBL] [Abstract][Full Text] [Related]
16. Introduction of Haemophilus influenzae type b (Hib) as pentavalent(DPT-HepB-Hib) vaccine in two states of India.
Gupta SK; Sosler S; Lahariya C
Indian Pediatr; 2012 Sep; 49(9):707-9. PubMed ID: 23024078
[No Abstract] [Full Text] [Related]
17. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
[TBL] [Abstract][Full Text] [Related]
18. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
[TBL] [Abstract][Full Text] [Related]
19. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules.
Miller MA; McCann L
Health Econ; 2000 Jan; 9(1):19-35. PubMed ID: 10694757
[TBL] [Abstract][Full Text] [Related]
20. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
Dhillon S
BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
